The Alzheimer's disease assessment scale - Cognitive subscale: Normative data for older adult controls

Alzheimer Disease and Associated Disorders

Volumn 18, Issue 4, 2004, Pages 236-240

  Graham, David P ^a,b   Cully, Jeffrey A ^a,b   Snow, A Lynn ^a,b   Massman, Paul ^c,d   Doody, Rachelle ^a,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d Baylor Coll Med Alzheimer's D C   (United States)

Author keywords

Alzheimer disease; Assessment; Dementia

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE COGNITIVE SUBSCALE; ARTICLE; COGNITION; COGNITIVE DEFECT; DATA ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; RECALL; SCORING SYSTEM;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION; EDUCATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; SEX FACTORS;

EID: 11344279030     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984;141:1356-1364.
2. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry. 1994;151:390-396.
3. Caro J, Ward A, Ishak K, et al. To what degree does cognitive impairment in Alzheimer's disease predict dependence of patients on caregivers? BMC Neurol. 2002;2:6.
4. Farias ST, Harrell E, Neumann C, et al. The relationship between neuropsychological performance and daily functioning in individuals with Alzheimer's disease: ecological validity of neuropsychological tests. Arch Clin Neuropsychol. 2003;18:655-672.
5. Hannesdottir K, Snaedal J. A study of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population. Nord J Psychiatry. 2002;56:201-206.
6. Tsolaki M, Fountoulakis K, Nakopoulou E, et al. Alzheimer's disease assessment scale: the validation of the scale in Greece in elderly demented patients and normal subjects. Dement Geriatr Cogn Disord. 1997;8:273-280.
7. Weyer G, Erzigkeit H, Kanowski S, et al. Alzheimer's disease assessment scale: Reliability and validity in a multicenter clinical trial. Int Psychogeriatr. 1997;9:123-138.
8. Inzitari D, Rossi R, Lamassa M, et al. Validity of different linguistic versions of the Alzheimer's disease assessment scale in an international multicentre Alzheimer's disease trial. Dement Geriatr Cogn Disord. 1999;10:269-277.
9. Chu LW, Chiu KC, Hui SL, et al. The reliability and validity of the Alzheimer's disease assessment scale cognitive subscale (ADAS-cog) among the elderly Chinese in Hong Kong. Ann Acad Med Singapore. 2000;29:474-485.
10. Liu HC, Teng EL, Chuang YY, et al. The Alzheimer's disease assessment scale: findings from a low-education population. Dement Geriatr Cogn Disord. 2002;13:21-26.
11. Pena-Casanova J, Aguilar M, Santacruz P, et al. Adaptation and normalization of the Alzheimer's disease Assessment Scale for Spain (NORMACODEM) (II). Neurologia. 1997;12:69-77.
12. Doraiswamy PM, Krishen A, Stallone F, et al. Cognitive performance of the Alzheimer's disease assessment scale: effect of education. Neurology. 1995;25:1980-1984.
13. Schultz RR, Siviero MO, Bertolucci PH. The cognitive subscale of the "Alzheimer's disease assessment scale" in a Brazilian sample. Braz J Med Biol Res. 2001;34:1295-1302.
14. Kolibas E, Korinkova V, Novotny V, et al. ADAS-cog (Alzheimer's Disease Assessment Scale - cognitive subscale) - validation of the Slovak version. Bratisl Lek Listy. 2000;101:598-602.
15. Zec RF, Landreth ES, Vicari SK, et al. Alzheimer disease assessment scale: useful for both early detection and staging of dementia of the Alzheimer type. Alzheimer Dis Assoc Disord. 1992a;6:89-102.
16. Doraiswamy PM, Bieber F, Kaiser L, et al. The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials. Neurology. 1997a;48:1511-1517.
17. Pena-Casanova J. Alzheimer's Disease Assessment Scale-cognitive in clinical practice. Int Psychogeriatr. 1997;9:105-114.
18. Doraiswamy PM, Bieber F, Kaiser L, et al. Memory, language, and praxis in Alzheimer's disease: norms for outpatient clinical trial populations. Psychopharmacol Bull. 1997b;33:123-128.
19. Schmeidler R, Mohs RC, Aryan M. Relationship of disease severity to decline on specific cognitive and functional measures in Alzheimer disease. Alzheimer Dis Assoc Disord. 1998;12:146-151.
20. Grundman M, Petersen RC, Ferris SH, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004;61:59-66.
21. Zec RF, Landreth ES, Vicari SK, et al. Alzheimer Disease Assessment Scale: a subtest analysis. Alzheimer Dis Assoc Disord. 1992b;6:164-181.
22. Salloway SP, Kumar D, Ieni J, et al. Benefits of Donepezil treatment in patients with Mild Cognitive Impairment. Neurology. 2003;60(Suppl 1):A411.
23. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State Examination. J Psychiatr Res. 1975;2:189-198.
24. SPSS for Windows version 11.5.0. SPSS Inc. Headquarters, 233 S. Wacker Drive, 11th floor Chicago, Illinois 60606. Copyright 1989-2002. http://www.spss.com.
25. Stata version 8.2. StataCorp, 4905 Lakeway Drive, College Station, Texas 77845 USA. Copyright 1984-2003: http://www.stata.com.
26. Gillen TE, Gregg KM, Yuan H, et al. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease. Psychopharmacol Bull. 2001;35:83-96.
27. Weyer G, Ihl R, Schambach M. Alzheimer's disease assessment scale (ADAS). Deutschsprachige Bearbeitung. Dokumentationsbogen und Testmaterial. Weinheim, Beltz, 1992.